US Bancorp DE Grows Holdings in DocuSign, Inc. (NASDAQ:DOCU)

US Bancorp DE boosted its holdings in shares of DocuSign, Inc. (NASDAQ:DOCUFree Report) by 12.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,561 shares of the company’s stock after purchasing an additional 398 shares during the period. US Bancorp DE’s holdings in DocuSign were worth $221,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the business. American Century Companies Inc. grew its holdings in shares of DocuSign by 1.9% during the second quarter. American Century Companies Inc. now owns 4,099,400 shares of the company’s stock worth $219,318,000 after buying an additional 75,026 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of DocuSign by 18.3% in the second quarter. Renaissance Technologies LLC now owns 3,729,314 shares of the company’s stock valued at $199,518,000 after purchasing an additional 576,414 shares during the period. Pacer Advisors Inc. raised its stake in shares of DocuSign by 77.9% during the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock worth $188,318,000 after purchasing an additional 1,541,816 shares during the last quarter. Jericho Capital Asset Management L.P. lifted its holdings in shares of DocuSign by 316.6% during the first quarter. Jericho Capital Asset Management L.P. now owns 3,417,908 shares of the company’s stock worth $203,536,000 after purchasing an additional 2,597,489 shares during the period. Finally, Clearbridge Investments LLC grew its position in DocuSign by 4.1% in the 2nd quarter. Clearbridge Investments LLC now owns 2,920,842 shares of the company’s stock valued at $156,265,000 after buying an additional 115,616 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

DocuSign Trading Down 1.8 %

NASDAQ:DOCU opened at $80.36 on Friday. The company has a market capitalization of $16.31 billion, a P/E ratio of 16.95, a price-to-earnings-growth ratio of 8.73 and a beta of 0.90. The firm has a 50-day moving average price of $66.18 and a two-hundred day moving average price of $59.18. DocuSign, Inc. has a twelve month low of $42.12 and a twelve month high of $83.68.

DocuSign (NASDAQ:DOCUGet Free Report) last issued its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The business had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. During the same period last year, the company posted $0.09 EPS. The company’s revenue was up 7.0% on a year-over-year basis. On average, equities research analysts predict that DocuSign, Inc. will post 1.01 earnings per share for the current year.

Wall Street Analysts Forecast Growth

DOCU has been the subject of several recent analyst reports. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research note on Friday, September 6th. Wells Fargo & Company lifted their price objective on DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a report on Friday, September 6th. JMP Securities reissued a “market outperform” rating and set a $84.00 target price on shares of DocuSign in a research note on Thursday, September 5th. Royal Bank of Canada lifted their price target on DocuSign from $52.00 to $57.00 and gave the company a “sector perform” rating in a research note on Friday, September 6th. Finally, Robert W. Baird increased their price objective on DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $63.40.

Check Out Our Latest Stock Analysis on DocuSign

Insider Buying and Selling

In other DocuSign news, insider Robert Chatwani sold 14,799 shares of the company’s stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total value of $820,752.54. Following the transaction, the insider now directly owns 70,748 shares in the company, valued at approximately $3,923,684.08. This represents a 17.30 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Allan C. Thygesen sold 7,764 shares of DocuSign stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now owns 107,825 shares of the company’s stock, valued at approximately $7,542,358.75. This trade represents a 6.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 69,558 shares of company stock worth $4,272,768. 1.66% of the stock is owned by corporate insiders.

About DocuSign

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Further Reading

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.